Moderna Announces Expansion of BARDA Agreement to Support Larger Phase 3 Program for Vaccine (mRNA-1273) Against COVID-19Business Wire • 07/26/20
Fauci: Coronavirus Vaccine Likely Not "Widely Available" Until Several Months Into 2021The Motley Fool • 07/24/20
Moderna Faces Hurdle With Coronavirus Vaccine As Court Refuses To Invalidate Arbutus PatentBenzinga • 07/24/20
Moderna Dives On Patent Battle That Could Jeopardize Coronavirus VaccineInvestors Business Daily • 07/23/20
Moderna Analyst Says Odds Are Good For COVID-19 Vaccine Approval, But Valuation OvercookedBenzinga • 07/23/20
Medidata Supports Moderna’s COVID-19 Vaccine Clinical Trials with Rave Clinical Cloud PlatformBusiness Wire • 07/23/20
Moderna to Report Second Quarter 2020 Financial Results on Wednesday, August 5, 2020Business Wire • 07/22/20
Everything You Need to Know About Operation Warp Speed's Coronavirus Vaccine AcceleratorThe Motley Fool • 07/22/20
Could These Findings Dramatically Change the Opportunities for COVID-19 Vaccine Stocks?The Motley Fool • 07/22/20
Pharma executives promise Congress they aren't cutting corners in fast tracking coronavirus vaccineCNBC • 07/21/20
What Does It Mean for Investors When a Coronavirus Vaccine Is "Fast-Tracked"?The Motley Fool • 07/21/20